TRACEY EMMONS: Open Payments
NPI 1386295293 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,949 in 102 payments from 36 companies in 2025. Trend: 2023 $1,911 · 2024 $2,901 · 2025 $2,949
Food & beverage: $2,899Education: $50
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $373 |
| AstraZeneca Pharmaceuticals LP | 11 | $344 |
| Novartis Pharmaceuticals Corporation | 15 | $313 |
| Daiichi Sankyo Inc. | 8 | $286 |
| ABBVIE INC. | 11 | $218 |
| Incyte Corporation | 4 | $179 |
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
| Gilead Sciences, Inc. | 1 | $101 |
| Merck Sharp & Dohme LLC | 5 | $95 |
| PFIZER INC. | 3 | $85 |
Products named: Enhertu, RYBREVANT, KISQALI, Monjuvi, BREYANZI, Trodelvy, KEYTRUDA, IBRANCE.
Industry payments across AZ — which companies pay providers there.
